Výsledky vyhľadávania - "Yazmin Odia"
-
1
Autori: a ďalší
Zdroj: Cancers; Jul2025, Vol. 17 Issue 13, p2107, 12p
Predmety: BRAIN tumor treatment, GLIOMA treatment, RISK assessment, GLIOMAS, RESEARCH funding, SCIENTIFIC observation, TREATMENT effectiveness, CANCER patients, RETROSPECTIVE studies, MULTIVARIATE analysis, DESCRIPTIVE statistics, HISTONES, ONCOGENES, RESEARCH, MEDICAL records, ACQUISITION of data, GENETIC mutation, CONFIDENCE intervals, DISEASE progression, OVERALL survival, BRAIN tumors, EVALUATION
Geografický termín: UNITED States
-
2
Autori: a ďalší
Zdroj: Oncologist; Mar2025, Vol. 30 Issue 3, p1-7, 7p
Predmety: COMMUNITY health services, RESEARCH funding, NEUROLOGISTS, NEUROSURGERY, QUALITATIVE research, MEDICAL quality control, CANCER patient medical care, QUESTIONNAIRES, CANCER patients, QUANTITATIVE research, PHYSICIANS' attitudes, NERVOUS system tumors, SURVEYS, EXPERIMENTAL design, MEDICAL radiology, RESEARCH methodology, ONCOLOGISTS, HEALTH care teams, INTEGRATED health care delivery
Geografický termín: CANADA, UNITED States
-
3
Autori:
Zdroj: Neuro-Oncology; 2024 Supplement, Vol. 26, pS89-S91, 3p
-
4
Autori: a ďalší
Zdroj: Cancers; Jun2025, Vol. 17 Issue 11, p1752, 15p
-
5
Autori: a ďalší
Zdroj: Neurology; 10/5/2021, Vol. 97 Issue 14, p675-684, 10p
-
6
Autori: a ďalší
Zdroj: Drug Delivery & Translational Research; Nov2025, Vol. 15 Issue 11, p4367-4410, 44p
-
7
Autori: a ďalší
Zdroj: Cancers; Mar2025, Vol. 17 Issue 6, p1046, 12p
Predmety: CEREBROSPINAL fluid examination, PROTON therapy, MEDICAL protocols, PATIENT safety, PILOT projects, LYMPHOPENIA, MENINGEAL cancer, TREATMENT effectiveness, DESCRIPTIVE statistics, CANCER patients, CENTRAL nervous system, TERTIARY care, KAPLAN-Meier estimator, COMPARATIVE studies, CONFIDENCE intervals, PROGRESSION-free survival, RADIATION doses, TOXICITY testing, OVERALL survival, PROPORTIONAL hazards models, REGRESSION analysis, NEUTROPENIA, BRAIN tumors
Geografický termín: UNITED States
-
8
Autori: a ďalší
Zdroj: JAMA Dermatology; Oct2023, Vol. 159 Issue 10, p1112-1118, 7p
-
9
Autori:
Zdroj: Neuro-Oncology; Feb2023, Vol. 25 Issue 2, p423-423, 1p
-
10
Autori: a ďalší
Zdroj: Neuro-Oncology; 2024 Supplement, Vol. 26, pS155-S164, 10p
-
11
Autori: a ďalší
Zdroj: Scientific Reports; 11/4/2024, Vol. 14 Issue 1, p1-12, 12p
-
12
Zdroj: Neuro-Oncology Advances; 2025 Supplement, Vol. 7, pii1-ii37, 164p
-
13
Autori: a ďalší
Zdroj: Clinical Pharmacology; Jul2025, Vol. 17, p185-209, 25p
-
14
Autori: a ďalší
Zdroj: Journal of Neuro-Oncology; Aug2024, Vol. 169 Issue 1, p105-117, 13p
-
15
Autori: a ďalší
Zdroj: Neurology: Clinical Practice; Dec2019, Vol. 9 Issue 6, p456-458, 3p
-
16
Autori: a ďalší
Zdroj: Clinical Pharmacology; May2025, Vol. 17, p97-117, 21p
-
17
Autori: a ďalší
Zdroj: Neuro-Oncology; 2024 Supplement, Vol. 26, pS165-S172, 8p
-
18
Autori: a ďalší
Zdroj: Neurology; 1/18/2022, Vol. 98 Issue 3, pe260-e266, 7p
-
19
Autori: a ďalší
Zdroj: Neuro-Oncology Advances; Jan-Dec2024, Vol. 6 Issue 1, p1-11, 11p
-
20
Autori: a ďalší
Zdroj: Neuro-Oncology Advances; 2023, Vol. 5 Issue 1, p1-3, 3p
Full Text Finder
Nájsť tento článok vo Web of Science